Acarix AB (publ) (“Acarix”), developer of the CADScor®System for Coronary Artery Disease (CAD) risk assessment, today announced the appointment of the company’s current CFO, Christian Lindholm as interim Chief Executive Officer. Lindholm replaces CEO Søren Rysholt Christiansen who announced his resignation on November 6th, 2017.

Read more

Acarix AB (publ) (“Acarix”) announced today that CEO Søren Rysholt Christiansen has resigned on 6 Nov.
2017, with the effect to leave the company at the end of February 2018 latest.

Read more